000			02329 a2200661 4500
005			20250516224219.0
264		0	_c20141216
008			201412s 0 0 eng d
022			_a1096-8652
024	7		_a10.1002/ajh.23814 _2doi
040			_aNLM _beng _cNLM
100	1		_aSahin, Ilyas
245	0	0	_aTargeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib. _h[electronic resource]
260			_bAmerican journal of hematology _cNov 2014
300			_a1030-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAminopyridines _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Adhesion _xdrug effects
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line
650	0	4	_aCell Line, Tumor
650	0	4	_aChemotaxis _xdrug effects
650	0	4	_aCoculture Techniques
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aFemale
650	0	4	_aFibronectins
650	0	4	_aHumans
650	0	4	_aMesenchymal Stem Cells _xcytology
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMorpholines _xpharmacology
650	0	4	_aMultiple Myeloma _xenzymology
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aRNA Interference
650	0	4	_aRNA, Small Interfering _xpharmacology
650	0	4	_aReceptors, CXCR4 _xbiosynthesis
650	0	4	_aWaldenstrom Macroglobulinemia _xenzymology
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aAzab, Feda
700	1		_aMishima, Yuji
700	1		_aMoschetta, Michele
700	1		_aTsang, Brian
700	1		_aGlavey, Siobhan V
700	1		_aManier, Salomon
700	1		_aZhang, Yu
700	1		_aSacco, Antonio
700	1		_aRoccaro, Aldo M
700	1		_aAzab, Abdel Kareem
700	1		_aGhobrial, Irene M
773	0		_tAmerican journal of hematology _gvol. 89 _gno. 11 _gp. 1030-6
856	4	0	_uhttps://doi.org/10.1002/ajh.23814 _zAvailable from publisher's website
999			_c24041511 _d24041511